Pombiliti 105 mg
Pombiliti 105 mg is a medicine authorised by Swissmedic under authorisation number 67804. The authorisation holder is Amicus Therapeutics Switzerland GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 July 2024 and the authorisation is limited until 03 July 2029. ATC code A16AB23 places the medicine in the group Other alimentary tract and metabolism products.
| Authorisation number | 67804 |
|---|---|
| Name | Pombiliti 105 mg |
| Full name | Pombiliti 105 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Amicus Therapeutics Switzerland GmbH |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | A16AB23 |
| First authorisation | 04 July 2024 |
| Authorisation validity | 03 July 2029 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Pombiliti 105 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 04 July 2024 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Ampulle(n) | A16AB23 | 07.14.0. | A |
| 2 | 10 | Ampulle(n) | A16AB23 | 07.14.0. | A |
| 3 | 25 | Ampulle(n) | A16AB23 | 07.14.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Pombiliti 105 mg authorised in Switzerland?
Yes. Pombiliti 105 mg is authorised by Swissmedic under authorisation number 67804, data as of 01 September 2026. The authorisation is limited until 03 July 2029.
Which dispensing category does Pombiliti 105 mg have?
Pombiliti 105 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Pombiliti 105 mg?
The authorisation holder is Amicus Therapeutics Switzerland GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.